Searched for
DRUG PATENT WAR
On This Day in History, June 26: UN Charter signed, Indira Gandhi declares Emergency, Harry Potter debuts, Corvette day, Sher Shah Suri wins against Mughals and moreOn This Day in History, June 26 saw the signing of the United Nations Charter, Richard III's rise to the English throne, India's declaratio...- Christy Mathai used market dip to buy insurance, logistics stocks; here's his sector-by-sector playbookFund Manager Christy Mathai sees easing war-driven inflation fears, expecting a shorter earnings hit. He's selectively adding to his portfo...
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Banking, financials remain strong play despite near-term volatility: Sunil SubramaniamCrude oil prices and UAE's role in OPEC+ are influencing Indian markets. Experts suggest oil prices may fall in the medium term, easing con...
- Semaglutide API price plunges amid GLP-1 rushGlobal demand for weight-loss drugs Ozempic and Wegovy has caused semaglutide prices to drop significantly. Manufacturing has expanded rapi...
- Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
- Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
- The United States drug industry used to oppose patents - what changed?Drugmakers quickly voiced their opposition to the move, but public health advocates were elated. Waiving patent rights, the thinking goes, ...
- Natco gets emergency use nod for Baricitinib to treat Covid without trialsIn a statement, the Hyderabad headquartered pharma company said Baricitinib in combination with Remdesivir is used for the treatment of Cov...
- Cipla asks government to revoke five patents held by NovartisCipla, India’s fifthlargest drugmaker by revenue, has asked the government to revoke five patents that Novartis holds on respiratory drug O...
- Rise in ex-parte orders upset generic drugmakers' future business plansCases where courts forbid Indian drugmakers from launching generic versions of patented drugs has rattled domestic pharma sector.
- Delhi High Court seeks Glenmark's response on US drug giant MSD's appealJustice S Ravindra Bhat and SK Mishra issued a notice to Glenmark and sought its reply by May 22 on the US firm's plea challenging the sing...
- Why SC ruling won't bring down drug pricesDespite the SC verdict, Indian generics makers won't be falling over each other to take on Big Pharma and launch cheaper versions of their ...
- Cipla defends strict patent lawsCipla said in the Supreme Court that India's patent laws have been made restrictive to increase the reach of life-saving drugs.
- Cipla’s patent win against Roche boosts hopes of generic drugmakersThe Delhi HC ruling favouring India’s second largest drugmaker Cipla has come as a shot in the arm for other generic makers who are fightin...
- Venus Remedies gets Australian patent approval for VancoplusDrug firm Venus Remedies today said it has received approval from the Australian Patent office (APO) for its product 'Vancoplus'.
- Natco victory could encourage other generic companies also to apply for compulsory licenceEarlier this week, a ruling effectively cut the price of high-cost cancer drug Sorafenib by 97%. But that’s just one of many legal battles ...
- MSF welcomes India's decision to reject drug patent to Roche'Medicins Sans Frontieres', an international medical humanitarian group, today welcomed India's decision to reject a patent granted to Swis...
- AIDS drug Viread prices may dip soonBlockbuster AIDS drug Viread is set to witness a price war in the domestic market in the next few days, benefitting lakhs of patients using...
- Of patents and pre-grant oppositionsOn January 25 this year, the patent office in Chennai rejected a patent application by pharma MNC Novartis for its anti-cancer drug Glivec ...
Load More
